To include your compound in the COVID-19 Resource Center, submit it here.
DISEASE CATEGORY: Hepatic
INDICATION: Non-alcoholic steatohepatitis (NASH)
Mouse studies suggest inhibiting GP1BB could help treat
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury